Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Proyavit is an oral nutraceutical product developed by Juvenor Pharmaceuticals, formulated as a combination of antioxidants, vitamins, and minerals. Its composition typically includes lycopene, vitamin A, vitamin E, vitamin C, and essential trace elements such as selenium, zinc, manganese, iodine, and copper. Proyavit is primarily used as a dietary supplement to support general health, enhance immune function, and provide antioxidant protection against oxidative stress. It is indicated for the management of nutritional deficiencies and as an adjunct in conditions where oxidative damage is a concern. The product is currently approved and marketed in India as part of Juvenor's nutritional portfolio.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Proyavit.